Skip to search formSkip to main contentSkip to account menu

Pentacel

Known as: PENTACEL DTaP-IPV-Hib vaccine 
National Institutes of Health

Related topics

Related topics

12 relations

Broader (12)

Bordetella pertussis filamentous hemagglutinin vaccine, inactivatedBordetella pertussis fimbriae 2/3 vaccine, inactivatedBordetella pertussis pertactin vaccine, inactivatedBordetella pertussis toxoid vaccine, inactivated

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Buccal Cellulitis in 3 Infants
Three patients are reported with buccal cellulitis. All were between 4 months and 6 months of age. Two patients had received two… 
2012
2012
Local Vaccine Site Reactions and Contact Allergy to Aluminum
Abstract:  Childhood vaccines are a routine part of pediatric care in the United States; clinicians must be able to recognize and… 
2007
2007
FDA Advisory Committee Recommends Licensure of New Pediatric Combination Vaccine - If approved, Pentacel vaccine would be the first pediatric combination vaccine in the U.S. to immunize against…
Bethesda, Md. – January 25, 2007 – Sanofi pasteur, the vaccines business of the sanofiaventis Group (NYSE: SNY; EURONEXT: SAN… 
Review
2006
Review
2006
Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL™ and ADACEL™
Acellular pertussis-containing combination vaccines are widely used in the developed world for the control of pertussis and have… 
2005
2005
Safety and Immunogenicity Comparison of a Fourth Dose of DTaP-IPV//PRP-T (Pentacel™) to the Separate Administration of DAPTACEL ® and ActHIB ®
Review
2005
Review
2005
Survey for Serious Adverse Events (SAEs) following Immunization with the 4 th Dose of a Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus and Haemophilus influenzae Type b Combination…
2005
2005
Effect of Pneumococcal Conjugate Vaccine (PCV-7) on Antibody Responses to Concomitantly Administered PENTACEL™ (DTaP-IPV//PRP-T) or Licensed Equivalent Vaccines
2005
2005
Safety and Immunogenicity of DTaP-IPV//PRP-T (Pentacel™) Coadministered with Pneumococcal Conjugate Vaccine (Prevnar ® ) at 2, 4, and 6 months of Age.
2005
2005
Pentacel Vaccine as Safe as Component Vaccines
2005
2005
Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15…
A DTaP-IPV//PRP-T combination vaccine (Pentacel™) has been universally used in Canada to provide immunization against diphtheria… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)